Intelligence Platform

Patents

Browse 99 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10435695

Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interf

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434167

Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing lipos

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10435461

Therapy for filovirus infection

granted patent

US 10400031

Identification of antibodies specific for lyssaviruses and methods of their use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10385319

Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183080

Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687542

Rift valley fever virus replicon particles and use thereof

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9079936

Derivatives of APF and methods of use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912316

Compositions and methods for inhibiting expression of CD45 gene

The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673292

Pure populations of astrocyte restricted precursor cells and methods for isolation and use

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076372

Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

The Government of the United States · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8043623

Immunogenic peptides for the treatment of prostate and breast cancer

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691386

Chimeric papillomavirus-like particles

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655247

Malaria vaccines

The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7311916

Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303751

Anti-plasmodium compositions and methods of use

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303754

MVA expressing modified HIV envelope, gag, and pol genes

granted patent

US 7235232

Interferon alpha hybrids

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7235365

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

granted patent

US 7045132

Streptococcus pneumoniae 37-kDa surface adhesin a protein

The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, c/o Centers for Disease Control and Prevention · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired